SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-121607
Filing Date
2022-04-27
Accepted
2022-04-27 07:43:54
Documents
13
Period of Report
2022-04-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d326843d8k.htm   iXBRL 8-K 25400
2 EX-99.1 d326843dex991.htm EX-99.1 23488
  Complete submission text file 0001193125-22-121607.txt   183149

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sldb-20220422.xsd EX-101.SCH 2861
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20220422_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20220422_pre.xml EX-101.PRE 11711
7 EXTRACTED XBRL INSTANCE DOCUMENT d326843d8k_htm.xml XML 3469
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

IRS No.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 22856389
SIC: 2836 Biological Products, (No Diagnostic Substances)